|
Friedman, Samuel R; Mateu-Gelabert, Pedro; Curtis, Richard et al. (2007) Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med 32:S160-70
|
|
Kottiri, Benny J; Friedman, Samuel R; Neaigus, Alan et al. (2002) Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr 30:95-104
|
|
Friedman, S R; Kottiri, B J; Neaigus, A et al. (2000) Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol 152:913-22
|
|
Friedman, S R; Curtis, R; Jose, B et al. (1999) The message not heard: myth and reality in discussions about syringe exchange. AIDS 13:738-9
|
|
Friedman, S R; Furst, R T; Jose, B et al. (1998) Drug scene roles and HIV risk. Addiction 93:1403-16
|
|
Friedman, S R; Neaigus, A; Jose, B et al. (1997) Sociometric risk networks and risk for HIV infection. Am J Public Health 87:1289-96
|
|
Friedman, S R (1996) Network methodologies, contact tracing, gonorrhea, and human immunodeficiency virus. Sex Transm Dis 23:523-5
|
|
Neaigus, A; Friedman, S R; Jose, B et al. (1996) High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 11:499-509
|
|
Goldstein, M F; Friedman, S R; Neaigus, A et al. (1995) Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction 90:1097-104
|
|
Friedman, S R; Jose, B; Deren, S et al. (1995) Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. Am J Epidemiol 142:864-74
|
Showing the most recent 10 out of 16 publications
